Evidence map›Paper›PMID 32506808›Full record

ArticleMolecular nutrition & food research2020

Bone-Specific Metabolism of Dietary Polyphenols in Resorptive Bone Diseases.

Andrew G Kunihiro, Paula B Luis, Jennifer B Frye, Wade Chew, H H Chow, Claus Schneider, Janet L Funk

Open access · greenAbstract read
In one paragraph

Article in Molecular nutrition & food research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Andrew G KunihiroDepartment of Nutritional Sciences, University of Arizona, Tucson, AZ, 85721, USA.
Paula B LuisDepartment of Pharmacology, Vanderbilt University, Nashville, TN, 37232, USA.
Jennifer B FryeDepartment of Medicine, University of Arizona, Tucson, AZ, 85724, USA.
Wade ChewUniversity of Arizona Cancer Center, University of Arizona, Tucson, AZ, 85719, USA.
H H ChowUniversity of Arizona Cancer Center, University of Arizona, Tucson, AZ, 85719, USA.
Claus SchneiderDepartment of Pharmacology, Vanderbilt University, Nashville, TN, 37232, USA.ORCID 0000-0003-4215-967X
Janet L FunkDepartment of Nutritional Sciences, University of Arizona, Tucson, AZ, 85721, USA.ORCID 0000-0002-9826-5407
University of Arizona · USVanderbilt University · US

Funding

VITAMIN AP30CA023074 · NCI · UNIVERSITY OF ARIZONA · PI Teri L Bankhead · 1985 to 2026
$110.2M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Oxidative activation of the dietary cancer chemopreventive agent curcuminR01AT006896 · NCCIH · VANDERBILT UNIVERSITY · PI SCHNEIDER, CLAUS · 2013 to 2017
$2.2M
Exploiting the Tumor Microenvironment to Block Breast Cancer Bone MetastasisR01CA174926 · NCI · UNIVERSITY OF ARIZONA · PI FUNK, JANET L · 2014 to 2018
$1.6M
Curcuma longa L. in Rheumatoid Arthritis (CLaRA): Clinical Planning StudyR34AT007837 · NCCIH · UNIVERSITY OF ARIZONA · PI FUNK, JANET L · 2013 to 2015
$737k
Bone-specific deglucuronidation of turmeric-derived curcuminoids for the treatment of osteolytic diseaseF31AT009938 · NCCIH · UNIVERSITY OF ARIZONA · PI KUNIHIRO, ANDREW GEORGE KENRO · 2018 to 2019
$61k
NCCIH NIH HHS F31 AT009938NCCIH NIH HHS R01 AT006896NCCIH NIH HHS R34 AT007837NCI NIH HHS P30 CA023074NCI NIH HHS R01 CA174926NIDDK NIH HHS P30 DK058404
6 · The paper itself

Abstract

scopeCurcumin prevents bone loss in resorptive bone diseases and inhibits osteoclast formation, a key process driving bone loss. Curcumin circulates as an inactive glucuronide that can be deconjugated in situ by bone's high β-glucuronidase (GUSB) content, forming the active aglycone. Because curcumin is a common remedy for musculoskeletal disease, effects of microenvironmental changes consequent to skeletal development or disease on bone curcumin metabolism are explored. METHODS AND

resultsAcross sexual/skeletal development or between sexes in C57BL/6 mice ingesting curcumin (500 mg kg

conclusionDietary polyphenols circulating as glucuronides may require in situ deconjugation for bone-protective effects, a process influenced by bone microenvironmental changes.

Indexed as

AgingAnimalsBone and BonesBone NeoplasmsCurcuminFemaleGlucuronidaseGlucuronidesMaleMice, Inbred C57BLOsteogenesisOsteolysisOsteoporosisOvariectomyPolyphenolsQuercetinCurcumincurcumin glucuronideGlucuronidaseGlucuronidesPolyphenolsQuercetinbonescurcuminosteoclastsosteoporosisquercetinresorptive bone diseasesresveratrol

Identifiers

PMID32506808
PMCPMC7712627
OpenAlexW3033555330

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.